Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_assertion type Assertion NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_head.
- NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_assertion description "[Our results provide evidence for the feasibility and efficacy of the modification of HSPC with CAR as a strategy for generating multiple lineages of effector cells for immunotherapy against B-lineage malignancies to augment graft-versus-leukemia activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_provenance.
- NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_assertion evidence source_evidence_literature NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_provenance.
- NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_assertion SIO_000772 23978226 NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_provenance.
- NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_assertion wasDerivedFrom befree-2016 NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_provenance.
- NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_assertion wasGeneratedBy ECO_0000203 NP1105474.RAZCSpQWSMKRE6TDR8mHnal2OFOQO5Gdbm3m7qEwNg1Ko130_provenance.